Biotech Institutional Investors

BioSniper tracks 3,104institutional investors with meaningful biotech & pharma exposure — each with their 13F portfolio across companies, total value held, and quarter-by-quarter ownership trends, sourced from SEC Form 13F filings. Showing the 300 largest by value held.